Clinical trial / 2016
In an uncontrolled open-label study, 1 of 19 newborn siblings given vitamin D regimens developed autism compared to ~20% in literature.
An open-label prospective study prescribed vitamin D at 5000 IU/day during pregnancy to mothers of children with autism, and 1000 IU/day to newborn siblings until their third birthday. Followed for three years and assessed at 18 and 36 months, 1 out of 19 (5%) newborn siblings developed autism, compared to an approximate 20% recurrence rate in the literature. The authors note the study is preliminary, had very small numbers, lacked blinding, and had no control group.
- Study type
- Open-label prospective uncontrolled study
- Who was studied
- 19 newborn siblings of children with autism and their mothers
- What was measured
- Recurrence of autism assessed at 18 and 36 months of age
THE PAPER
Autism: Will vitamin D supplementation during pregnancy and early childhood reduce the recurrence rate of autism in newborn siblings?
Stubbs G, Henley K, Green J. Med Hypotheses, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.